Sanofi-Aventis Raises Genzyme Bid
February 02, 2011 at 00:17 AM EST
France’s Sanofi-Aventis has agreed to raise its bid for Genzyme (GENZ) to the low $70′s per share range, plus a milestone payment based on the performance of an experimental drug, a source familiar with the situation told Reuters on Tuesday.
